Christopher D. Roberts - Net Worth and Insider Trading

Christopher D. Roberts Net Worth

The estimated net worth of Christopher D. Roberts is at least $7,936 dollars as of 2025-06-30. Christopher D. Roberts is the Chief Scientific Officer of Black Diamond Therapeutics Inc and owns about 3,200 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $7,936. Details can be seen in Christopher D. Roberts's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher D. Roberts has not made any transactions after 2021-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Christopher D. Roberts

Christopher D. Roberts Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher D. Roberts owns 1 companies in total, including Black Diamond Therapeutics Inc (BDTX) .

Click here to see the complete history of Christopher D. Roberts’s form 4 insider trades.

Insider Ownership Summary of Christopher D. Roberts

Ticker	Company	Transaction Date	Type of Owner
BDTX	Black Diamond Therapeutics Inc	2021-03-03	Chief Scientific Officer

Christopher D. Roberts Latest Holdings Summary

Christopher D. Roberts currently owns a total of 1 stock. Christopher D. Roberts owns 3,200 shares of Black Diamond Therapeutics Inc (BDTX) as of March 3, 2021, with a value of $7,936.

Latest Holdings of Christopher D. Roberts

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BDTX	Black Diamond Therapeutics Inc	2021-03-03	3,200	2.48	7,936

Holding Weightings of Christopher D. Roberts

Christopher D. Roberts Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher D. Roberts has made a total of 8 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Black Diamond Therapeutics Inc is the sale of 2,500 shares on March 3, 2021, which brought Christopher D. Roberts around $65,250.

Insider Trading History of Christopher D. Roberts

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher D. Roberts Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher D. Roberts Ownership Network

Ownership Network List of Christopher D. Roberts

No Data

Ownership Network Relation of Christopher D. Roberts

Christopher D. Roberts Owned Company Details

What does Black Diamond Therapeutics Inc do?

Who are the key executives at Black Diamond Therapeutics Inc?

Christopher D. Roberts is the Chief Scientific Officer of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , 10 percent owner Versant Venture Capital Vi, L.p. , and director & 10 percent owner Ali Behbahani .

Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary

Over the past 18 months, Christopher D. Roberts made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net sale of 5,784,292 shares made by Biotech Growth N V , and a net sale of 221,600 shares made by Versant Venture Capital Vi, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,005,892 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,005,892 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Black Diamond Therapeutics Inc Insider Transactions

No Available Data

Christopher D. Roberts Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher D. Roberts. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher D. Roberts's mailing address is: Cambridge Ma 02142.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.